Literature DB >> 20559531

A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant.

Yun-Jung Oh1, Young-Min Park, Sun-Pyo Hong, Soo-Kyeong Shin, Seung-Il Ji, Bo-Hyun Kim, Sang-Jong Park, Zheng Hong.   

Abstract

A 47-year-old woman underwent orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related end-stage liver cirrhosis. The patient received hepatitis B immunoglobulin prophylaxis after OLT. Despite the protective level of the serum anti-hepatitis-B surface antibody, HBV recurred at 22 months post-OLT and induced subacute hepatic failure. The pre-OLT HBV genome contained a complex mutation pattern in overlapping frame regions of the surface (S) and polymerase (P) genes, which is the same mutation pattern as seen in post-OLT HBV DNA. G145R and K141R mutations in the "a" determinant were detected only in the post-OLT sample. Clevudine (30 mg once daily) was administered for recurrent hepatitis B. Hepatitis B was reactivated with a flare-up, and a M204I mutation (YIDD mutant type) appeared with a higher viral load at 9 months after clevudine treatment. We report here a case of a YIDD mutation that developed in recurrent hepatitis B after OLT induced by an S-escape mutant.

Entities:  

Keywords:  G145R; G1896A; Liver transplantation; Recurrent hepatitis B; rtM204I

Year:  2010        PMID: 20559531      PMCID: PMC2886939          DOI: 10.5009/gnl.2010.4.2.253

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  25 in total

1.  Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.

Authors:  K Al Faraidy; E M Yoshida; J E Davis; R K Vartanian; F H Anderson; U P Steinbrecher
Journal:  Transplantation       Date:  1997-09-27       Impact factor: 4.939

Review 2.  Histologic findings in recurrent HBV.

Authors:  Swan N Thung
Journal:  Liver Transpl       Date:  2006-11       Impact factor: 5.799

3.  Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.

Authors:  D Samuel; A Bismuth; D Mathieu; J L Arulnaden; M Reynes; J P Benhamou; C Brechot; H Bismuth
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

4.  Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.

Authors:  W F Carman; C Trautwein; F J van Deursen; K Colman; E Dornan; G McIntyre; J Waters; V Kliem; R Müller; H C Thomas; M P Manns
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

Review 5.  Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis.

Authors:  L Grellier; G M Dusheiko
Journal:  J Viral Hepat       Date:  1997       Impact factor: 3.728

6.  Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.

Authors:  U Protzer; B Goergen; U Hopf; P Neuhaus; V König; K H Meyer zum Büschenfelde; G Gerken
Journal:  J Med Virol       Date:  1996-10       Impact factor: 2.327

7.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

Authors:  M G Ghany; B Ayola; F G Villamil; R G Gish; S Rojter; J M Vierling; A S Lok
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

8.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.

Authors:  U Protzer-Knolle; U Naumann; R Bartenschlager; T Berg; U Hopf; K H Meyer zum Büschenfelde; P Neuhaus; G Gerken
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

9.  Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant.

Authors:  J W Fang; F Y Tung; G L Davis; D J Dolson; D H Van Thiel; J Y Lau
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

10.  Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.

Authors:  C Trautwein; H Schrem; H L Tillmann; S Kubicka; D Walker; K H Böker; H J Maschek; R Pichlmayr; M P Manns
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.